The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): Guidance from the society for healthcare epidemiology of America (SHEA)

Thomas R. Talbot; Hilary Babcock; Deborah Cotton; Lisa L. Maragakis; Gregory A. Poland; Edward J. Septimus; Michael L. Tapper; David J. Weber

doi:10.1086/667772

The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): Guidance from the society for healthcare epidemiology of America (SHEA)

Thomas R. Talbot, Hilary Babcock, Deborah Cotton, Lisa L. Maragakis, Gregory A. Poland, Edward J. Septimus, Michael L. Tapper, David J. Weber

General Internal Medicine

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America regarding use of LAIV in HCP and the infection control precautions that are recommended with its use in this population.

Original language	English (US)
Pages (from-to)	981-983
Number of pages	3
Journal	Infection Control and Hospital Epidemiology
Volume	33
Issue number	10
DOIs	https://doi.org/10.1086/667772
State	Published - Oct 2012

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/667772

Cite this

Talbot, T. R., Babcock, H., Cotton, D., Maragakis, L. L., Poland, G. A., Septimus, E. J., Tapper, M. L., & Weber, D. J. (2012). The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): Guidance from the society for healthcare epidemiology of America (SHEA). Infection Control and Hospital Epidemiology, 33(10), 981-983. https://doi.org/10.1086/667772

The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): Guidance from the society for healthcare epidemiology of America (SHEA). / Talbot, Thomas R.; Babcock, Hilary; Cotton, Deborah et al.
In: Infection Control and Hospital Epidemiology, Vol. 33, No. 10, 10.2012, p. 981-983.

Research output: Contribution to journal › Article › peer-review

@article{04bfbe59160e4685bc5f0b61a350df09,

title = "The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): Guidance from the society for healthcare epidemiology of America (SHEA)",

abstract = "Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America regarding use of LAIV in HCP and the infection control precautions that are recommended with its use in this population.",

author = "Talbot, {Thomas R.} and Hilary Babcock and Deborah Cotton and Maragakis, {Lisa L.} and Poland, {Gregory A.} and Septimus, {Edward J.} and Tapper, {Michael L.} and Weber, {David J.}",

year = "2012",

month = oct,

doi = "10.1086/667772",

language = "English (US)",

volume = "33",

pages = "981--983",

journal = "Infection Control and Hospital Epidemiology",

issn = "0899-823X",

publisher = "University of Chicago Press",

number = "10",

}

TY - JOUR

T1 - The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP)

T2 - Guidance from the society for healthcare epidemiology of America (SHEA)

AU - Talbot, Thomas R.

AU - Babcock, Hilary

AU - Cotton, Deborah

AU - Maragakis, Lisa L.

AU - Poland, Gregory A.

AU - Septimus, Edward J.

AU - Tapper, Michael L.

AU - Weber, David J.

PY - 2012/10

Y1 - 2012/10

N2 - Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America regarding use of LAIV in HCP and the infection control precautions that are recommended with its use in this population.

AB - Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America regarding use of LAIV in HCP and the infection control precautions that are recommended with its use in this population.

UR - http://www.scopus.com/inward/record.url?scp=84866150437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866150437&partnerID=8YFLogxK

U2 - 10.1086/667772

DO - 10.1086/667772

M3 - Article

C2 - 22961016

AN - SCOPUS:84866150437

SN - 0899-823X

VL - 33

SP - 981

EP - 983

JO - Infection Control and Hospital Epidemiology

JF - Infection Control and Hospital Epidemiology

IS - 10

ER -

The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): Guidance from the society for healthcare epidemiology of America (SHEA)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this